Maso Capital Partners’s Epizyme, Inc EPZM Stock Holding History

Maso Capital Partners’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-20,000	Closed	-$945K	–	64
2020 Q4	$945K	Buy	+20,000	New	+$247K	0.26%	36

Other funds holding EPZM

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KXA

KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Maso Capital Partners's EPZM Position: Q1 2021 in Review

Maso Capital Partners sold out of Epizyme, Inc (EPZM) in Q1 2021, closing a stake of 20,000 shares — an estimated $945K sold.

Maso Capital Partners first reported a position in EPZM in Q4 2020 and held it in 1 quarter. The position peaked at $945K in Q4 2020. 137 funds tracked by Wall St. Rank hold EPZM as of Q1 2021.

Maso Capital Partners reported no remaining Epizyme, Inc position as of Q1 2021 after selling out during the quarter.
Maso Capital Partners sold 20,000 Epizyme, Inc shares in Q1 2021, an estimated $945K.
Maso Capital Partners first reported a position in Epizyme, Inc in Q4 2020 and held it in 1 quarter.
Maso Capital Partners's Epizyme, Inc position peaked at $945K in Q4 2020.
137 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2021.

Based on Maso Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.